Kureha Chemical Industry's Proprietary Anti-Chronic Renal Failure Agent KREMEZIN Now Available In Korea
10/19/2005 5:12:37 PM
More...
|
NexMed (NEXM) Announces Femprox(R) License Agreement For South Korea
10/19/2005 5:10:04 PM
More...
|
BioTime (BTX) Announces Regulatory Approval Of Hextend In South Korea; Receives Second License Fee From CJ Corp.
10/19/2005 5:08:57 PM
More...
|